FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
|Articles|July 1, 2020
- Pharmaceutical Technology Buyers' Guide 2020
- Volume 2020 Special Issue
Pharmaceutical Technology 2020 Buyers' Guide
Find connections to suppliers of the materials, equipment, and services you need to develop, manufacture, and distribute crucial therapies, treatments, and vaccines in the 2020 Pharmaceutical Technology Buyers' Guide.
Advertisement
Pharmaceutical Technology’s annual Buyers’ Guide is the leading directory of thousands of suppliers of ingredients, materials, and other resources needed for the development and manufacture of solid dose, parenteral, biologic, inhalation, transdermal, and other drug forms.
Use the following links for fast reference to specific technologies and services:
Chemicals, raw materials, intermediates, and excipients Manufacturing equipment and supplies Cleanroom equipment and supplies Packaging equipment and accessories Laboratory equipment and supplies Information technologies Outsourcing services .
In addition, read about trends and innovations in the guide’s
For more online resources, visit the
Advertisement
Related to this article
AI accountability, faster FDA pathways, rare disease CMC review, and next-gen GLP-1 formulation lead this week’s PharmTech roundup.
MASH and cardiomyopathy AI collaboration: AstraZeneca pays insitro $40M upfront for target discovery, then leads clinical development and CMC planning.
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about rare disease treatment development and navigating the FDA’s Rare Pediatric Disease Priority Review Voucher Program.
NVIDIA’s $250M, five-year compute donation funds UK agentic AI safety research, with implications for how GMP teams validate and govern autonomous AI.
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
2
AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing
3
Nitrosamine Problems and Industry Solutions: PharmTech Explained
4
FDA Approves Bepirovirsen: Why Oligonucleotide CDMOs Should Take Note
5